"Study Finds Lower Suicidal Ideation Risk in Users of Diabetes, Weight Loss Drugs Ozempic and Wegovy"
TL;DR
A study funded by the NIH has found that semaglutide, a medication used to treat obesity and type 2 diabetes, is associated with a significantly lower risk of suicidal ideation compared to other treatments. The research, which analyzed electronic health records, showed a 49% to 73% lower risk for patients treated with semaglutide. These findings counter anecdotal reports suggesting a potential increase in suicidal thoughts among users of the drug. The study emphasizes the need for further investigation into the long-term effects of semaglutide on mental health and suicide attempts.
Topics:businesshealth-and-medicine##health-and-medicine#mentalhealth#obesity#semaglutide#suicidalideation#type2diabetes
- Semaglutide associated with lower risk of suicidal ideations compared to other treatments prescribed for obesity or type 2 diabetes National Institutes of Health (.gov)
- FDA looking into reports of hair loss, suicidal thoughts in people using popular drugs for diabetes and weight loss WLWT Cincinnati
- Weight loss drug warning FOX 26 Houston
- Ozempic, Wegovy not associated with higher risk of suicidal ideation in large review of US health records CNN
- Ozempic and Wegovy Users Had Less Risk of Suicidal Thoughts in Large Study The New York Times
Want the full story? Read the original reporting
Read on National Institutes of Health (.gov)